In Melanoma, Personalized Treatment Vaccines Show Promise

Results of an early-phase trial showed that a treatment vaccine personalized to a specific patient’s cancer generated a robust immune response against the cancer and may have helped to prevent it from returning.

Cancer Currents: An NCI Cancer Research Blog